The evolving schistosomiasis agenda 2007-2017—Why we are moving beyond morbidity control toward elimination of transmission

Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis

(2017) Gisele Andrade et al.   PLoS Neglected Tropical Diseases

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy

(2016) Amaya L. Bustinduy et al.   mBio

Preventive Chemotherapy Versus Innovative and Intensified Disease Management in Neglected Tropical Diseases: A Distinction Whose Shelf Life Has Expired

(2016) Mark Rosenberg et al.   PLoS Neglected Tropical Diseases

Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis

(2016) Amaya L. Bustinduy et al.   PLoS Neglected Tropical Diseases

Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa

(2015) David Gurarie et al.   Parasites & Vectors

Historical Perspective: Snail Control to Prevent Schistosomiasis

(2015) Charles H. King et al.   PLoS Neglected Tropical Diseases

A Five-Country Evaluation of a Point-of-Care Circulating Cathodic Antigen Urine Assay for the Prevalence of Schistosoma mansoni

(2013) Daniel G. Colley et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Projecting the Long-Term Impact of School- or Community-Based Mass-Treatment Interventions for Control of Schistosoma Infection

(2012) Xiaoxia Wang et al.   PLoS Neglected Tropical Diseases

The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002–2008

(2009) A. FENWICK et al.   PARASITOLOGY